279 related articles for article (PubMed ID: 27694308)
1. Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells.
Rank L; Veith S; Gwosch EC; Demgenski J; Ganz M; Jongmans MC; Vogel C; Fischbach A; Buerger S; Fischer JM; Zubel T; Stier A; Renner C; Schmalz M; Beneke S; Groettrup M; Kuiper RP; Bürkle A; Ferrando-May E; Mangerich A
Nucleic Acids Res; 2016 Dec; 44(21):10386-10405. PubMed ID: 27694308
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
3. PARP1 catalytic variants reveal branching and chain length-specific functions of poly(ADP-ribose) in cellular physiology and stress response.
Aberle L; Krüger A; Reber JM; Lippmann M; Hufnagel M; Schmalz M; Trussina IREA; Schlesiger S; Zubel T; Schütz K; Marx A; Hartwig A; Ferrando-May E; Bürkle A; Mangerich A
Nucleic Acids Res; 2020 Oct; 48(18):10015-10033. PubMed ID: 32667640
[TBL] [Abstract][Full Text] [Related]
4. PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response.
Reber JM; Božić-Petković J; Lippmann M; Mazzardo M; Dilger A; Warmers R; Bürkle A; Mangerich A
Cell Biol Toxicol; 2023 Feb; 39(1):345-364. PubMed ID: 35778544
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
[TBL] [Abstract][Full Text] [Related]
6. PARP1 protects from benzo[a]pyrene diol epoxide-induced replication stress and mutagenicity.
Fischer JMF; Zubel T; Jander K; Fix J; Trussina IREA; Gebhard D; Bergemann J; Bürkle A; Mangerich A
Arch Toxicol; 2018 Mar; 92(3):1323-1340. PubMed ID: 29196784
[TBL] [Abstract][Full Text] [Related]
7. The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.
Kamaletdinova T; Fanaei-Kahrani Z; Wang ZQ
Cells; 2019 Dec; 8(12):. PubMed ID: 31842403
[TBL] [Abstract][Full Text] [Related]
8. Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy.
Krüger A; Bürkle A; Hauser K; Mangerich A
Nat Commun; 2020 May; 11(1):2174. PubMed ID: 32358582
[TBL] [Abstract][Full Text] [Related]
9. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribosyl)ation as a new posttranslational modification of YB-1.
Alemasova EE; Pestryakov PE; Sukhanova MV; Kretov DA; Moor NA; Curmi PA; Ovchinnikov LP; Lavrik OI
Biochimie; 2015 Dec; 119():36-44. PubMed ID: 26453809
[TBL] [Abstract][Full Text] [Related]
11. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S
Nucleic Acids Res; 2020 Sep; 48(17):9694-9709. PubMed ID: 32890402
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.
Fischbach A; Krüger A; Hampp S; Assmann G; Rank L; Hufnagel M; Stöckl MT; Fischer JMF; Veith S; Rossatti P; Ganz M; Ferrando-May E; Hartwig A; Hauser K; Wiesmüller L; Bürkle A; Mangerich A
Nucleic Acids Res; 2018 Jan; 46(2):804-822. PubMed ID: 29216372
[TBL] [Abstract][Full Text] [Related]
13. A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.
Singh HR; Nardozza AP; Möller IR; Knobloch G; Kistemaker HAV; Hassler M; Harrer N; Blessing C; Eustermann S; Kotthoff C; Huet S; Mueller-Planitz F; Filippov DV; Timinszky G; Rand KD; Ladurner AG
Mol Cell; 2017 Dec; 68(5):860-871.e7. PubMed ID: 29220653
[TBL] [Abstract][Full Text] [Related]
14. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
Lu J; Zhang R; Hong H; Yang Z; Sun D; Sun S; Guo X; Ye J; Li Z; Liu P
Biochim Biophys Acta; 2016 Dec; 1863(12):3027-3039. PubMed ID: 27686254
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage.
Liu HY; Liu YY; Zhang YL; Ning Y; Zhang FL; Li DQ
Cell Commun Signal; 2022 Aug; 20(1):127. PubMed ID: 35986334
[TBL] [Abstract][Full Text] [Related]
16. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
17. Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter.
Tian YN; Chen HD; Tian CQ; Wang YQ; Miao ZH
Cell Death Dis; 2020 Jan; 11(1):71. PubMed ID: 31992690
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of poly(ADP-ribosyl)ation, but not PARP1 itself, determines the cell fate in response to DNA damage in vitro and in vivo.
Schuhwerk H; Bruhn C; Siniuk K; Min W; Erener S; Grigaravicius P; Krüger A; Ferrari E; Zubel T; Lazaro D; Monajembashi S; Kiesow K; Kroll T; Bürkle A; Mangerich A; Hottiger M; Wang ZQ
Nucleic Acids Res; 2017 Nov; 45(19):11174-11192. PubMed ID: 28977496
[TBL] [Abstract][Full Text] [Related]
19. Insight into DNA substrate specificity of PARP1-catalysed DNA poly(ADP-ribosyl)ation.
Matta E; Kiribayeva A; Khassenov B; Matkarimov BT; Ishchenko AA
Sci Rep; 2020 Feb; 10(1):3699. PubMed ID: 32111879
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase 1 regulates mitochondrial DNA repair in an NAD-dependent manner.
Herrmann GK; Russell WK; Garg NJ; Yin YW
J Biol Chem; 2021; 296():100309. PubMed ID: 33482196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
